[CRVS] YoY Quarter Result on 31-Dec-2020 [#Q4]

Stock
[CRVS] Corvus Pharmaceuticals, Inc.
Announcement Date
25-Mar-2021
Financial Year
2020
Quarter
31-Dec-2020 [#Q4]
Profit Trend
QoQ- 379.16%
YoY- 347.55%
Quarter Report
CRVS's Result
CRVS's Financial Summary
View:
Show?
Quarter Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 246 0 0 0 0 0 0 -
PBT -6,653 -9,816 -9,236 27,347 -11,047 -10,509 -11,929 -9.26%
Tax -95 6,384 8 -143 -185 -180 -219 -12.98%
NP -6,653 -16,200 -9,236 27,347 -11,047 -10,509 -11,929 -9.26%
Tax Rate - - - 0.52% - - - -
Total Cost 6,899 16,200 9,236 -27,347 11,047 10,509 11,929 -8.71%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin -2,704.47 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS -0.14 -0.35 -0.20 0.92 -0.38 -0.36 -0.58 -21.08%
EPS Diluted -0.14 -0.35 -0.20 0.92 -0.38 -0.36 -0.58 -21.08%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.